Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Akhtar, Sayeed
and
Mukherjee, Sujoy
1993.
Chloroquine Induced Mania.
The International Journal of Psychiatry in Medicine,
Vol. 23,
Issue. 4,
p.
349.
Gribble, Fiona M
Davis, Timothy M E
Higham, Claire E
Clark, Anne
and
Ashcroft, Frances M
2000.
The antimalarial agent mefloquine inhibits ATP‐sensitive K‐channels.
British Journal of Pharmacology,
Vol. 131,
Issue. 4,
p.
756.
O’Shaughnessy, Thomas J
Zim, Bret
Ma, Wu
Shaffer, Kara M
Stenger, David A
Zamani, Kaveh
Gross, Guenter W
and
Pancrazio, Joseph J
2003.
Acute neuropharmacologic action of chloroquine on cortical neurons in vitro.
Brain Research,
Vol. 959,
Issue. 2,
p.
280.
Ferraro, V.
Mantoux, F.
Denis, K.
Lay-Macagno, M.-A.
Ortonne, J.-P.
and
Lacour, J.-P.
2004.
Hallucinations au cours d’un traitement par hydroxychloroquine.
Annales de Dermatologie et de Vénéréologie,
Vol. 131,
Issue. 5,
p.
471.
Sahoo, Saddichha
Kumar, Manoj
and
Sinha, Vinod K
2007.
Chloroquine-Induced Recurrent Psychosis.
American Journal of Therapeutics,
Vol. 14,
Issue. 4,
p.
406.
Rani, Seema
Grover, Sandeep
Mehra, Aseem
and
Sahoo, Swapnajeet
2020.
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
Indian Journal of Pharmacology,
Vol. 52,
Issue. 3,
p.
229.
Askarian, Fatemeh
Firoozi, Zahra
Ebadollahi-Natanzi, Alireza
Bahrami, Solmaz
and
Rahimi, Hamid-Reza
2022.
A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients.
Toxicological Research,
Vol. 38,
Issue. 2,
p.
137.
eLetters
No eLetters have been published for this article.